Clinical Trial: ECOG-ACRIN E3A06

ECOG-ACRIN E3A06

Status: Closed

Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients with Asymptomatic High-Risk Smoldering Multiple Myeloma

E3A06 is closed to accrual effective July 14, 2017 at 5:00pm ET.